Gracell Biotechnologies Inc GRCL:NASDAQ

RT Quote | NASDAQ | USD
Last | 02/25/21 EST
23.51quote price arrow down-0.81 (-3.33%)
Volume
72,305
52 week range
20.12 - 33.70

...

Loading . . .

KEY STATS

  • Open24.80
  • Day High24.95
  • Day Low23.28
  • Prev Close23.51
  • 52 Week High33.70
  • 52 Week High Date02/04/21
  • 52 Week Low20.12
  • 52 Week Low Date01/28/21
  • Market Cap308.22M
  • Shares Out13.11M
  • 10 Day Average Volume0.07M
  • Dividend-
  • Dividend Yield-
  • Beta
  • 1 Year % Change-

RATIOS/PROFITABILITY

  • EPS (TTM)-0.44
  • P/E (TTM)-53.42
  • Fwd P/E (NTM)-31.30
  • EBITDA (MRQ)-24.984M
  • ROE (MRQ)-
  • Revenue (MRQ)0.00
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)24.60%

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest Gracell Biotechnologies Inc News

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
Gracell Biotechnologies Inc is a China-based clinical-stage biopharmaceutical company focused on discovering and developing cell therapies for the treatment of cancers. The Company is primarily focused on disrupting conventional approaches to chimeric antigen receptor (CAR) thymus (T) cell therapies by leveraging its technology platforms FasTCAR and TruUCAR. With FasTCAR, the Company is able to deliver younger, less exhausted T cells for autologous cell therapies with...
Address
Building 3
418 Guilin Road, Xuhui District
Shanghai, SHA
200030
China